ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 56 filers reported holding ONCOCYTE CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,988,000 | +8.9% | 2,035,891 | 0.0% | 0.31% | +67.4% |
| Q4 2019 | $4,581,000 | -10.2% | 2,035,891 | -16.2% | 0.19% | -17.3% |
| Q3 2019 | $5,103,000 | -13.9% | 2,430,180 | +2.1% | 0.23% | -3.8% |
| Q2 2019 | $5,927,000 | -39.7% | 2,380,180 | -4.4% | 0.24% | -40.4% |
| Q1 2019 | $9,836,000 | – | 2,490,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 2,982,557 | $5,697,000 | 6.44% |
| BROADWOOD CAPITAL INC | 14,716,204 | $28,108,000 | 2.20% |
| PURA VIDA INVESTMENTS, LLC | 5,983,724 | $11,429,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 99,282 | $190,000 | 0.90% |
| P.A.W. CAPITAL CORP | 200,000 | $382,000 | 0.43% |
| Penbrook Management LLC | 215,625 | $412,000 | 0.40% |
| EAM Investors, LLC | 241,769 | $462,000 | 0.10% |
| Private Wealth Partners, LLC | 150,000 | $287,000 | 0.04% |
| Phoenix Holdings Ltd. | 292,275 | $597,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 145,650 | $470,000 | 0.02% |